The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Hormone Replacement Therapy, Inflammation, and Hemostasis in Elderly Women
Abstract
Abstract —Lipid-lowering by postmenopausal hormone therapy (HRT) explains only partly the assumed coronary risk reduction associated with therapy. To explore other possible mechanisms, we studied associations of HRT use with inflammation and hemostasis risk markers in women ≥65 years of age. Subjects were selected from 3393 participants in the fourth year examination of the Cardiovascular Health Study, an observational study of vascular disease risk factors. After excluding women with vascular disease, we compared levels of inflammation and hemostasis variables in the 230 women using unopposed estrogen and 60 using estrogen/progestin, with those of 196 nonusers selected as controls. Compared with nonusers, unopposed estrogen use was associated with 59% higher mean C-reactive protein ( P <0.001), but with modestly lower levels of other inflammation indicators, fibrinogen, and alpha-1 acid glycoprotein ( P <0.001). Factor VIIc was 16% higher among estrogen users ( P <0.001), but this was not associated with higher thrombin production (prothrombin fragment 1-2), or increased fibrin breakdown (D-dimer). Concentration of plasminogen activator inhibitor-1 was 50% lower in both using groups ( P <0.001) compared with nonusers, and this was associated with higher plasmin-antiplasmin complex: 8% higher in estrogen and 18% higher in estrogen/progestin users ( P <0.05). Relationships between the markers and hormone use were less pronounced in estrogen/progestin users, with no association for C-reactive protein except in women in upper 2 tertiles of body mass index ( P for interaction, 0.02). The direction and strength of the associations of HRT use with inflammation markers differed depending on the protein, so it is not clear whether HRT confers coronary risk reduction through an inflammation-sensitive mechanism. Associations with hemostasis markers indicated no association with evidence of procoagulation and a possible association with increased fibrinolytic activity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hulley, S. (1998) · JAMA · doi:10.1001/jama.280.7.605 · Cited by 6,216
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
Ridker, P. M., Cushman, M., Stampfer, M. J., Tracy, R. P., & Hennekens, C. H. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704033361401 · Cited by 5,504
Self-citationThe Cardiovascular Health Study: design and rationale.
Fried, L. P., Borhani, N. O., Enright, P., Furberg, C. D., Gardin, J. M., Kronmal, R. A., Kuller, L. H., Manolio, T. A., Mittelmark, M. B., Newman, A., et al. (1991) · Annals of Epidemiology · doi:10.1016/1047-2797(91)90005-w · Cited by 3,652
Self-citationValery (1995) · doi:10.1001/jama.1995.03520270033028 · Cited by 2,320
Tracy, R. P., Lemaitre, R. N., Psaty, B. M., Ives, D. G., Evans, R. W., Cushman, M., Meilahn, E. N., & Kuller, L. H. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.6.1121 · Cited by 836
Self-citationCorti, M.-C., Salive, M. E., & Guralnik, J. M. (1996) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(95)00562-5 · Cited by 107
Cited by
Estrogen plus Progestin and the Risk of Coronary Heart Disease
Manson, J. E., Hsia, J., Johnson, K. C., Rossouw, J. E., Assaf, A. R., Lasser, N. L., Trevisan, M., Black, H. R., Heckbert, S. R., Detrano, R., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030808 · Cited by 2,065
Self-citationRidker, P. M. (2001) · Circulation · doi:10.1161/01.cir.103.13.1813 · Cited by 1,402
Effects of Estrogen Replacement on the Progression of Coronary-Artery Atherosclerosis
Herrington, D. M., Reboussin, D. M., Brosnihan, K. B., Sharp, P. C., Shumaker, S. A., Snyder, T. E., Furberg, C. D., Kowalchuk, G. J., Stuckey, T. D., Rogers, W. J., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200008243430801 · Cited by 1,242
Walston, J. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.20.2333 · Cited by 940
“Serum levels of CRP increase in response to acute or chronic illness and inflammatory states.(13,17,19) While its exact role remains controversial, CRP may act to amplify both inflammation and clotting through a number of pathways.”
BackgroundMethodEstrogen in the Prevention of Atherosclerosis: A Randomized, Double-Blind, Placebo-Controlled Trial
Hodis, H. N., Mack, W. J., Lobo, R. A., Shoupe, D., Sevanian, A., Mahrer, P. R., Selzer, R. H., Liu, C.-R., Liu, C.-H., Azen, S. P., et al. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-135-11-200112040-00005 · Cited by 687
Pradhan, A. D., Manson, J. E., Rossouw, J. E., Siscovick, D. S., Mouton, C. P., Rifai, N., Wallace, R. B., Jackson, R. D., Pettinger, M. B., & Ridker, P. M. (2002) · JAMA · doi:10.1001/jama.288.8.980 · Cited by 680
Cushman, M., Legault, C., Barrett-Connor, E., Stefanick, M. L., Kessler, C., Judd, H. L., Sakkinen, P. A., & Tracy, R. P. (1999) · Circulation · doi:10.1161/01.cir.100.7.717 · Cited by 660
Self-citationEstrogen Regulation of Growth Hormone Action
Leung, K.-C., Johannsson, G., Leong, G. M., & Ho, K. K. Y. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0035 · Cited by 542
Insulin Resistance and Inflammation as Precursors of Frailty: The Cardiovascular Health Study
Barzilay, J. I. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.7.635 · Cited by 453
Hormone Replacement Therapy and Increased Plasma Concentration of C-Reactive Protein
Ridker, P. M., Hennekens, C. H., Rifai, N., Buring, J. E., & Manson, J. E. (1999) · Circulation · doi:10.1161/01.cir.100.7.713 · Cited by 443
Estrogen replacement therapy, atherosclerosis, and vascular function
Mikkola, T. (2002) · Cardiovascular Research · doi:10.1016/s0008-6363(01)00466-7 · Cited by 420
Familial and genetic determinants of systemic markers of inflammation: the NHLBI family heart study
Pankow, J. S., Folsom, A. R., Cushman, M., Borecki, I. B., Hopkins, P. N., Eckfeldt, J. H., & Tracy, R. P. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(00)00586-4 · Cited by 375
Self-citationHUMAN ALPHA-1-GLYCOPROTEIN AND ITS INTERACTIONS WITH DRUGS†,‡
Israili, Z. H., & Dayton, P. G. (2001) · Drug Metabolism Reviews · doi:10.1081/dmr-100104402 · Cited by 367
Herrington, D. M., Howard, T. D., Brosnihan, K. B., McDonnell, D. P., Li, X., Hawkins, G. A., Reboussin, D. M., Xu, J., Zheng, S. L., Meyers, D. A., et al. (2002) · Circulation · doi:10.1161/01.cir.0000016173.98826.88 · Cited by 338
Walsh, B. W., Paul, S., Wild, R. A., Dean, R. A., Tracy, R. P., Cox, D. A., & Anderson, P. W. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.1.6326 · Cited by 326
Self-citationMenopause and aging: Changes in the immune system—A review
Gameiro, C. M., Romão, F., & Castelo-Branco, C. (2010) · Maturitas · doi:10.1016/j.maturitas.2010.08.003 · Cited by 303
Reduction in C-reactive protein through cardiac rehabilitation and exercise training
Milani, R. V., Lavie, C. J., & Mehra, M. R. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.10.041 · Cited by 302
Heikkilä, K., Harris, R., Lowe, G., Rumley, A., Yarnell, J., Gallacher, J., Ben-Shlomo, Y., Ebrahim, S., & Lawlor, D. A. (2009) · Cancer Causes & Control · doi:10.1007/s10552-008-9212-z · Cited by 290
C‐Reactive Protein (CRP)‐Lowering Agents
Prasad, K. (2006) · Cardiovascular Drug Reviews · doi:10.1111/j.1527-3466.2006.00033.x · Cited by 272
Vehkavaara, S., Silveira, A., Hakala-Ala-Pietilä, T., Virkamäki, A., Hovatta, O., Hamsten, A., Taskinen, M.-R., & Yki-Järvinen, H. (2001) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1615643 · Cited by 270
Albert, M. A., Glynn, R. J., & Ridker, P. M. (2003) · Circulation · doi:10.1161/01.cir.0000080289.72166.cf · Cited by 269
Relationship of total and abdominal adiposity with CRP and IL-6 in women
Rexrode, K. M., Pradhan, A., Manson, J. E., Buring, J. E., & Ridker, P. M. (2003) · Annals of Epidemiology · doi:10.1016/s1047-2797(03)00053-x · Cited by 262
Albert, M. A., Glynn, R. J., Buring, J., & Ridker, P. M. (2004) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2004.01.067 · Cited by 259
Sex steroids as inflammatory regulators
Gilliver, S. C. (2010) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2009.12.015 · Cited by 198
Cosman, F., Baz-Hecht, M., Cushman, M., Vardy, M. D., Cruz, J. D., Nieves, J. W., Zion, M., & Lindsay, R. (2005) · Thrombosis Research · doi:10.1016/j.thromres.2004.09.014 · Cited by 98
Self-citationSanders, J. L., Boudreau, R. M., Fried, L. P., Walston, J. D., Harris, T. B., & Newman, A. B. (2011) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2011.03557.x · Cited by 71
“Methods of phlebotomy sample handling and quality assurance have been described previously.(23) C-reactive protein (CRP) was assessed using a high-sensitivity enzyme-linked immunosorbent assay using purified protein and polyclonal anticlonal anti-CRP antibodies.”
MethodLowe, G. D. O. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01400.x · Cited by 54
Metadata
- Authors
- Cushman, M., Meilahn, E. N., Psaty, B. M., Kuller, L. H., Dobs, A. S., & Tracy, R. P.
- Venue
- Arteriosclerosis, Thrombosis, and Vascular Biology
- Published
- 1999-04
- Volume
- 19
- Issue
- 4
- Pages
- 893-899
- ISSN
- 1079-5642 (ISSN-L)
- 1524-4636
- OpenAlex
- W2069086684
- Cited by
- 218
- References
- 6
- FWCI
- 17.87
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.